Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
University of Pittsburgh
Merck Sharp & Dohme LLC
Medivir
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Georgetown University
Celldex Therapeutics
Xencor, Inc.
Peking Union Medical College Hospital
SMT bio Co., Ltd.
National Institutes of Health Clinical Center (CC)